Cathie Wood’s ARK Rebalances Portfolio: Sells Alphabet, Buys Meta

Key Facts

1Cathie Wood's ARK Investment Management sold 84,392 shares of Alphabet totaling $28.55 million.

2The fund purchased 43,091 shares of Meta Platforms worth $26.44 million and 271,159 shares of Beam Therapeutics.

In a move reflecting an active management strategy to reallocate capital, Cathie Wood’s ARK Investment Management executed a significant rebalancing of its portfolio. The fund sold 84,392 shares of Alphabet totaling $28.55 million, shifting its focus toward the social media and biotechnology sectors. These trades included the purchase of 43,091 shares in Meta Platforms worth $26.44 million and the acquisition of 271,159 shares in Beam Therapeutics.

These adjustments occur amid varying price levels for tech giants, with Alphabet (GOOGL) closing at $330.65 on September 9, 2026, while Meta Platforms (META) stood at $653.69 on the same date per market data. In comparison to industry peers, Microsoft (MSFT) closed at $491.65 and Apple (AAPL) at $315.34, highlighting the valuation landscape of the mega-cap technology firms targeted by the fund's current strategy.

Traders should watch META's performance following its $653.69 close on September 9, 2026, as the fund continues to build its position. While specific price data for Beam Therapeutics is unavailable, institutional flow remains a key sentiment driver. Markets are also looking ahead to macroeconomic catalysts such as U.S. Initial Jobless Claims and Services PMI data which may impact risk appetite in the growth sector.